Hemorrhagic Kaposi sarcoma. Successful treatment with IFN-alpha

dc.contributor.authorBassioukas, K.en
dc.contributor.authorZioga, A.en
dc.contributor.authorHantschke, M.en
dc.contributor.authorKlouvas, G.en
dc.contributor.authorHatzis, J.en
dc.date.accessioned2015-11-24T19:14:14Z
dc.date.available2015-11-24T19:14:14Z
dc.identifier.issn1167-1122-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21272
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectBiopsy, Needleen
dc.subjectDose-Response Relationship, Drugen
dc.subjectDrug Administration Scheduleen
dc.subjectFemaleen
dc.subjectFollow-Up Studiesen
dc.subjectHemorrhage/drug therapy/pathologyen
dc.subjectHumansen
dc.subjectImmunohistochemistryen
dc.subjectInjections, Subcutaneousen
dc.subjectInterferon-alpha/*administration & dosageen
dc.subjectRecombinant Proteinsen
dc.subjectRisk Assessmenten
dc.subjectSarcoma, Kaposi/*drug therapy/*pathologyen
dc.subjectSkin Neoplasms/*drug therapy/*pathologyen
dc.subjectTreatment Outcomeen
dc.titleHemorrhagic Kaposi sarcoma. Successful treatment with IFN-alphaen
heal.abstractA 76-year-old woman with atypical hemorrhagic Kaposi sarcoma is presented. The patient was treated with recombinant interferon alpha-2b (3,000,000 IU) subcutaneously, three times weekly for 6 months and twice weekly as maintenance dose for 14 months with excellent response and no recurrence after a 7 years of follow-up.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/14965794-
heal.journalNameEur J Dermatolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2004-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: